slows the progression of carotid stenosis in patients with isolated
systolic hypertension. Stroke 1994;25:44-50.
69. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R, et al.
Carotid intima-media thickness and antihypertensive treatment: a
meta-analysis of randomized controlled trials. Stroke 2006;37:
1933-40.
70. Wagenknecht LE, D’Agostino R Jr, Savage PJ, O’Leary DH, Saad MF,
Haffner SM. Duration of diabetes and carotid wall thickness. The
Insulin Resistance Atherosclerosis Study (IRAS). Stroke 1997;28:
999-1005.
71. Dobs AS, Nieto FJ, Szklo M, Barnes R, Sharrett AR, Ko WJ. Risk factors for
popliteal and carotid wall thicknesses in the Atherosclerosis Risk in
Communities (ARIC) Study. Am J Epidemiol 1999;150:1055-67.
72. Scholtes VP, Peeters W, van Lammeren GW, Howard DP, de Vries JP,
de Borst GJ, et al. Type 2 diabetes is not associated with an altered
plaque phenotype among patients undergoing carotid revascularization. A histological analysis of 1455 carotid plaques. Atherosclerosis 2014;235:418-23.
73. Smith NL, Barzilay JI, Shaffer D, Savage PJ, Heckbert SR, Kuller LH,
et al. Fasting and 2-hour postchallenge serum glucose measures
and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. Arch Intern Med 2002;162:209-16.
74. Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C,
Vieira JR, et al. Duration of diabetes and risk of ischemic stroke: the
Northern Manhattan Study. Stroke 2